The moderate or high expression rate for VEGFA was 35.7% (n = 15), with 19 patients (45.2%) exhibiting moderate or high immunohistochemical staining for VEGFB in the cytoplasm of cervical cancer cells (Supplementary Figure S1). This evidence concerns the gene VEGFB and cervical carcinoma.